Integer (NYSE:ITGR) Reaches New 52-Week High After Analyst Upgrade

Integer Holdings Co. (NYSE:ITGR)’s share price reached a new 52-week high during mid-day trading on Monday after KeyCorp raised their price target on the stock from $139.00 to $144.00. KeyCorp currently has an overweight rating on the stock. Integer traded as high as $132.00 and last traded at $131.87, with a volume of 118980 shares. The stock had previously closed at $129.24.

Other equities research analysts have also recently issued reports about the stock. Oppenheimer assumed coverage on shares of Integer in a research note on Tuesday, July 16th. They set an “outperform” rating and a $135.00 price target on the stock. Truist Financial raised their price target on shares of Integer from $145.00 to $150.00 and gave the stock a “buy” rating in a research note on Monday. Bank of America raised their price target on shares of Integer from $135.00 to $145.00 and gave the stock a “buy” rating in a research note on Tuesday, October 1st. Benchmark reiterated a “buy” rating and set a $130.00 price objective on shares of Integer in a report on Wednesday, October 2nd. Finally, Citigroup increased their price objective on shares of Integer from $124.00 to $130.00 and gave the stock a “neutral” rating in a report on Tuesday, October 1st. One equities research analyst has rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $138.71.

Insider Transactions at Integer

In other Integer news, Director Jean M. Hobby sold 11,960 shares of Integer stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $119.66, for a total value of $1,431,133.60. Following the completion of the transaction, the director now owns 2,280 shares of the company’s stock, valued at $272,824.80. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. Corporate insiders own 2.00% of the company’s stock.

Institutional Trading of Integer

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Contravisory Investment Management Inc. increased its holdings in shares of Integer by 55.9% in the 3rd quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 80 shares during the period. Quest Partners LLC boosted its position in Integer by 3,688.9% during the second quarter. Quest Partners LLC now owns 341 shares of the medical equipment provider’s stock worth $39,000 after purchasing an additional 332 shares during the period. GAMMA Investing LLC boosted its position in Integer by 60.9% during the second quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider’s stock worth $43,000 after purchasing an additional 142 shares during the period. Headlands Technologies LLC bought a new stake in Integer during the first quarter worth approximately $106,000. Finally, Innealta Capital LLC bought a new stake in Integer during the second quarter worth approximately $110,000. Institutional investors and hedge funds own 99.29% of the company’s stock.

Integer Stock Down 0.7 %

The stock has a market cap of $4.40 billion, a P/E ratio of 45.49, a PEG ratio of 1.86 and a beta of 1.08. The company has a quick ratio of 1.96, a current ratio of 3.29 and a debt-to-equity ratio of 0.73. The business has a 50-day simple moving average of $125.84 and a 200-day simple moving average of $120.34.

Integer (NYSE:ITGR) last posted its quarterly earnings data on Thursday, July 25th. The medical equipment provider reported $1.30 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.06. Integer had a return on equity of 11.48% and a net margin of 6.31%. The company had revenue of $436.20 million during the quarter, compared to analysts’ expectations of $437.00 million. During the same period in the prior year, the business earned $1.14 earnings per share. Integer’s revenue for the quarter was up 9.0% compared to the same quarter last year. Analysts expect that Integer Holdings Co. will post 5.3 EPS for the current year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.